Dibutyl squarate structure
|
Common Name | Dibutyl squarate | ||
---|---|---|---|---|
CAS Number | 2892-62-8 | Molecular Weight | 226.269 | |
Density | 1.1±0.1 g/cm3 | Boiling Point | 353.2±0.0 °C at 760 mmHg | |
Molecular Formula | C12H18O4 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | 157.2±30.7 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Name | squaric acid dibutyl ester |
---|---|
Synonym | More Synonyms |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 353.2±0.0 °C at 760 mmHg |
Molecular Formula | C12H18O4 |
Molecular Weight | 226.269 |
Flash Point | 157.2±30.7 °C |
Exact Mass | 226.120514 |
PSA | 52.60000 |
LogP | 1.97 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.477 |
Water Solubility | INSOLUBLE |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H317-H319-H335 |
Precautionary Statements | P261-P280-P305 + P351 + P338 |
Personal Protective Equipment | Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
Hazard Codes | Xn:Harmful; |
Risk Phrases | R36/37/38;R42/43 |
Safety Phrases | S26-S27-S36/37/39-S45 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | GU1772066 |
HS Code | 2914509090 |
~92% Dibutyl squarate CAS#:2892-62-8 |
Literature: Canadian Journal of Chemistry, , vol. 64, p. 2267 - 2273 |
~65% Dibutyl squarate CAS#:2892-62-8 |
Literature: Chemische Berichte, , vol. 113, # 1 p. 1 - 8 |
~97% Dibutyl squarate CAS#:2892-62-8 |
Literature: Synthetic Communications, , vol. 27, # 12 p. 2177 - 2180 |
HS Code | 2914509090 |
---|---|
Summary | HS:2914509090 other ketones with other oxygen function VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0% |
Adjunctive trichloroacetic acid therapy enhances squaric acid response to verruca vulgaris.
Journal. of. Drugs in. Dermatology. 11(10) , 1228-30, (2012) Squaric acid dibutyl ester (SADBE) is a commonly used treatment for verruca vulgaris of childhood. Few studies, however, have examined the role of SADBE in combination with other topical therapies for... |
|
Biphenyls as potent vitronectin receptor antagonists. Part 3: Squaric acid amides.
Bioorg. Med. Chem. Lett. 17(22) , 6151-4, (2007) Vitronectin receptor (alpha(V)beta(3)) antagonists have been implicated as a possible new treatment of restenosis following balloon angioplasty. In this work we investigate a series of novel arginine ... |
|
Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata.
Clin. Exp. Immunol. 135(3) , 398-408, (2004) The acute phase of alopecia areata (AA) is characterized by an increase in CD44v3+ and CD44v10+ skin-infiltrating leucocytes (SkIL). Induction of a contact eczema, one of the therapeutic options in AA... |
MFCD00037150 |
3,4-di-n-Butoxy-3-cyclobutene-1,2-dione |
3,4-Dibutoxy-3-cyclobutene-1,2-dione |
squaric acid dibutyl ester |
Squaric acid di-n-butyl ester |
SADBE |
3-Cyclobutene-1,2-dione, 3,4-dibutoxy- |
Di-n-butyl squarate |
1,2-dibutyl squarate |
dibutylsquarate |
1,2-dibutoxy-1-cyclobutene-3,4-dione |
Dibutyl squarate |
3,4-dibutoxycyclobut-3-ene-1,2-dione |
3,4-di-n-butyl-3-cyclobutene-1,2-dione |
Squaric acid dibutylester |